Your session is about to expire
← Back to Search
Parent-Child Assistance Program for Substance Use During Pregnancy
N/A
Recruiting
Led By Erin Maher, Ph.D.
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured every six months up to 4 years
Awards & highlights
No Placebo-Only Group
Summary
This trial helps 200 mothers in Oklahoma who use alcohol/drugs during pregnancy & their children by providing support/resources for 3 years. Benefits include substance use disorder treatment, birth control, abstinence, child custody, & criminal justice involvement.
Who is the study for?
This trial is for women over 18 in Oklahoma City or Tulsa who used alcohol, opioids, or drugs during pregnancy. It's for those pregnant or with a child under 24 months exposed to substances and not linked to services, or have a child with fetal alcohol spectrum disorder and are at risk of drinking while able to have more children.
What is being tested?
The Parent-Child Assistance Program (PCAP) is being tested. It supports mothers who've used substances during pregnancy by providing three years of case management. The study aims to help them get treatment, recover, access resources for independent living, and prevent future substance use in pregnancy.
What are the potential side effects?
Since PCAP involves social support rather than medical intervention, there aren't typical 'side effects' like you'd expect from medication. However, participants may experience emotional distress or other psychological impacts as they work through the program's requirements.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured every six months up to 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured every six months up to 4 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in abstinence
Change in using a reliable method(s) of birth control
Secondary study objectives
Change in child custody
Change in criminal justice involvement
Change in education
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
The treatment group consists of women who have used alcohol, opioids, or other drugs during pregnancy and their children. Mothers who are randomly assigned to the treatment group will receive PCAP services through the work of highly trained, closely supervised case managers.
Group II: Control GroupActive Control1 Intervention
The control group consists of women who have used alcohol, opioids, or other drugs during pregnancy and their children. Women in the control group will be provided with a service resource list and receive services as usual, but they will not be enrolled in PCAP.
Find a Location
Who is running the clinical trial?
Oklahoma Human ServicesUNKNOWN
1 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Fetal Alcohol Spectrum Disorders
80 Patients Enrolled for Fetal Alcohol Spectrum Disorders
OU Dodge Family College of Arts and SciencesUNKNOWN
University of Oklahoma OutreachUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Treatment Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger